Who is sponsoring NCT03341624?

NCT03341624 is sponsored by Yune Zhao.

What drugs are being tested in NCT03341624?

Interventions in NCT03341624: cataract surgery cataract extraction and intraocular implantation.

What condition does NCT03341624 study?

NCT03341624 studies Persistent Fetal Vasculature, Congenital Cataract.

Is NCT03341624 still recruiting?

NCT03341624 is currently status unknown. Last updated 14 November 2017.

Last reviewed 2017-11-14 · How we verify

NCT03341624

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Congenital Cataract With Persistent Fetal Vasculature

Status unknown NA Last updated 14 November 2017

What this trial tests

NA trial testing cataract surgery cataract extraction and intraocular implantation in Persistent Fetal Vasculature in 30 participants. Status unknown.

Timeline

1 January 2017

Primary endpoint
31 December 2018

31 December 2019

Quick facts

Lead sponsor	Yune Zhao
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	30
Start date	1 January 2017
Primary completion	31 December 2018
Estimated completion	31 December 2019
Sites	1 location across China

Drugs / interventions tested

cataract surgery cataract extraction and intraocular implantation

Conditions studied

Persistent Fetal Vasculature — all drugs for Persistent Fetal Vasculature →
Congenital Cataract — all drugs for Congenital Cataract →

Sponsor

Yune Zhao — full company profile →

Who can join

Eligibility, any sex, with Persistent Fetal Vasculature or Congenital Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To observe the clinical characteristics and surgical treatment of 24 cases of congenital cataract complicated with Persistent Fetal Vasculature (PFV) in 28 cases of congenital cataract in our hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Persistent Fetal Vasculature

Currently open trials in the same condition.

NCT06520410 — Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries · Phase 4 · recruiting

Other Yune Zhao trials

Trials by the same sponsor.

NCT05594537 — The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation · unknown
NCT05201677 — Improved Operation of Low Intraocular Pressure in Phacoemulsification for Patients With High Myopia Complicated With Cat · NA · unknown
NCT04636372 — Effect of Meibomian Gland Related Therapy on the Morphology of Meibomian Gland · NA · withdrawn
NCT04824755 — Reduced ER-QOL in Families After Congenital Cataract Surgery · NA · completed
NCT04487795 — Age-related Changes of Crystalline Lens Tilt and Decentration: A Swept-source Optical Coherence Tomography Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03341624 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yune Zhao
Last refreshed: 14 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03341624.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing